CN Patent

CN119350337A — 一类氘代哌啶酮酸酰胺氮杂茚满类cgrp抑制剂药物及用途

Assigned to Yaokang Zhongtuo Beijing Pharmaceutical Technology Co ltd · Expires 2025-01-24 · 1y expired

What this patent protects

本发明公开了一类氘代哌啶酮酸酰胺氮杂茚满类茚满类化合物、其立体异构体、互变异构体及其药学上可接受的盐，如下式Ⅰ所示，本发明涉及氘代CGRP抑制剂、其药物组合物及用途 。

USPTO Abstract

本发明公开了一类氘代哌啶酮酸酰胺氮杂茚满类茚满类化合物、其立体异构体、互变异构体及其药学上可接受的盐，如下式Ⅰ所示，本发明涉及氘代CGRP抑制剂、其药物组合物及用途 。

Drugs covered by this patent

Patent Metadata

Patent number
CN119350337A
Jurisdiction
CN
Classification
—
Expires
2025-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Yaokang Zhongtuo Beijing Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.